Pain Management Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Live Coverage of PAINWeek 2014

Exclusive access to live, onsite coverage of up-to-date evidence-based scientific findings in pain management.

Persistent Pain in Older Patients

Persistent pain in later life is prevalent, costly, and often disabling to patients.

Marijuana Laws Reduce Overdoses

State medical cannabis laws correlate with reduced state-level opioid overdose mortality rates.

DEA: Combo Hydrocodone Changes

The DEA has published the Final Rule moving hydrocodone combination products (HCPs) from Schedule III to Schedule II.

No Steroids for Shoulder Pain?

For relief of shoulder pain, physical therapy and steroid shots provide similar results.

Acetaminophen vs. Placebo for Back Pain

A new study published in The Lancet questions whether acetaminophen is an effective treatment for low-back pain.

Antiepileptics in Migraine Prophylaxis

An updated review of the use of antiepileptic drugs as preventive treatment for episodic migraine has been recently published.

New Drug Product: Zubsolv

Maintenance treatment of opioid dependence, as part of a complete treatment plan to include counseling and psychosocial support.


Accidental Ingestion of These Drugs Send Kids to ER the Most

From 2007-2011, there were nearly 10,000 emergency hospitalizations per year for unsupervised prescription medication ingestion by young children.

Aleve PM Available for Overnight Pain Relief

Bayer HealthCare announced the launch of Aleve PM (naproxen and diphenhydramine) caplets for occasional sleeplessness associated with minor aches and pains.

Should Aspirin for Primary CVD Prevention Be Routinely Recommended?

Prescribing aspirin for primary cardiovascular disease (CVD) prevention should be judged on an individual basis by health care providers.

Opioid Overdose Prevention Needed in Young Adult Users

Many young adult nonmedical prescription opioid (PO) users are relatively uninformed about overdose awareness, avoidance, and response strategies.

Lannett Approved for Oxycodone HCl Oral Solution

Lannett announced it has received approval from the Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Oxycodone HCl Oral Solution, the equivalent of Lehigh Valley Technologies' listed reference.

Featured courses from mycme

End-of-Life CareExternal web site

Discussing end-of-life issues and palliative care options with patients who have life-limiting illnesses is challenging. ...

CME|CE 1.25 Credits

Pain Management Workshop (Pharmacology Credit)External web site

This program will discuss the causes of chronic pain as well as pharmacological options for ...

CE 3.00 Credits

Debridement Training: Principles & PracticeExternal web site

This course offers practicing physicians, mid-level practitioners, nurses and other allied health professionals a comprehensive ...

CME|CE 4.00 Credits

Sign Up for Free e-newsletters